WFG Advisors’s La Jolla Pharmaceutical Company LJPC Stock Holding History

WFG Advisors’s Portfolio LJPC Stock Details LJPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$2K	Buy	+60	New	+$1.72K	﹤0.01%	1453
2017 Q1	–	Sell	-360	Closed	-$6K	–	1780
2016 Q4	$6K	Buy	360 +240	+200%	+$4.6K	﹤0.01%	1250
2016 Q3	$3K	Hold	120	–	–	﹤0.01%	1381
2016 Q2	$2K	Hold	120	–	–	﹤0.01%	1425
2016 Q1	$3K	Hold	120	–	–	﹤0.01%	1320
2015 Q4	$3K	Hold	120	–	–	﹤0.01%	1344
2015 Q3	$3K	Hold	120	–	–	﹤0.01%	1386
2015 Q2	$3K	Sell	120 -500	-81%	-$10.3K	﹤0.01%	1458
2015 Q1	$11K	Buy	620 +500	+417%	+$10.1K	﹤0.01%	1189
2014 Q4	$2K	Sell	120 -260	-68%	-$3.09K	﹤0.01%	1925
2014 Q3	$4K	Sell	380 -373	-50%	-$3.71K	﹤0.01%	1764
2014 Q2	$7K	Sell	753 -586	-44%	-$5.35K	﹤0.01%	1596
2014 Q1	$14K	Buy	+1,339	New	+$13.1K	﹤0.01%	1387

Other funds holding LJPC

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

WFG Advisors's LJPC Position: Q2 2017 in Review

WFG Advisors opened a new position in La Jolla Pharmaceutical Company (LJPC) in Q2 2017: 60 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #1453 among its holdings. This is a return to the name: WFG Advisors previously reported a position in LJPC as recently as Q4 2016.

WFG Advisors first reported a position in LJPC in Q1 2014 and has held it in 13 quarters since. The position peaked at $14K in Q1 2014. 83 funds tracked by Wall St. Rank hold LJPC as of Q2 2017.

WFG Advisors held 60 shares of La Jolla Pharmaceutical Company worth $2K as of Q2 2017.
La Jolla Pharmaceutical Company was a new WFG Advisors position in Q2 2017.
La Jolla Pharmaceutical Company made up ﹤0.01% of WFG Advisors's portfolio in Q2 2017, its #1453 holding.
WFG Advisors first reported a position in La Jolla Pharmaceutical Company in Q1 2014 and has held it in 13 quarters since.
WFG Advisors's La Jolla Pharmaceutical Company position peaked at $14K in Q1 2014.
83 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q2 2017.

Based on WFG Advisors's 13F filing for Q2 2017, filed 18 Aug 2017.